Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of TNXP: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders45138−6
Shares9.32M17.66M−1.65M (−17.7%)
Value$3.63M$0$4.53M+$901.9K (+24.9%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (2)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to TNXP in Q1 2023
InstitutionSharesValue% of portfolio
Sawtooth Solutions, LLC36,670$21.7K0.00%
Advisory Services Network, LLC1$10.00%

Sold out (8)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of TNXP in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Exchange Traded Concepts, LLC23,152$9.03K
Jane Street Group, LLC15,240$5.94K
Millennium Management LLC13,305$5.00K
StoneX Group Inc.12,728$4.96K
Condor Capital Management10,000$3.90K
Allworth Financial LP1,000$390
FMR LLC1$0
Russell Investments Group, Ltd.1$0

Not filed for Q1 2023 yet (1)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TNXP in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
CoreCap Advisors, LLC1$0